Report/Paper/Issue Brief

May 2021, SAMHSA revised certain areas of all five parts of this TIP to bring the content up to date and make it as useful to readers as possible. These changes will help provide readers with the latest information needed to understand medications for opioid use disorder.

This toolkit is intended to give prescribers a broad overview of medication utilization management techniques and describe ways that prescribers can facilitate patient access to needed medications. It focuses on prescribed medications that are filled by retail pharmacies.

The Population Health Management Resource Guide for Behavioral Health helps providers and payers better integrate the delivery or management of behavioral health care and physical care. Implementing best practices from this guide improves access and outcomes for populations with behavioral health conditions.

This guidance publication is intended to support the efforts of states, tribes, and local communities in addressing the needs of pregnant women with opioid use disorders and their infants and families.

This brief provides summary findings from a 2019, pre-pandemic review of the evidence of telebehavioral health's effectiveness on key clinical outcomes. It also describes the programmatic structure and relevant telebehavioral health policies of three programs: Texas Medicaid, Massachusetts Medicaid, and the Portland Veterans Affairs Medical Center Rural Telemental Health Program.

This brief provides an overview of state Medicaid opioid use disorder (OUD) care delivery innovations and offers recent examples from state Medicaid programs based on findings from an OUD policy inventory of nine state Medicaid programs that have been substantially impacted by the opioid epidemic and participate in the Medicaid Outcomes Distributed Research Network.

This primer examines the policy levers available to improve access and quality of substance use disorder treatment and recovery services.

This policy brief explores strategies for ensuring people in jails and prisons have uninterrupted access to medications for opioid use disorder (MOUD) during the pandemic. These include taking advantage of a new federal waiver that allows providers to initiate MOUD via telemedicine, without a prior physical examination; providing adequate medication supplies upon release; and offering virtual counseling and peer support.

This white paper reviews cybersecurity risks, regulatory issues, policies and procedures, audit tools, and best practices in the use and management of telehealth and telemedicine, and offers recommendation for addressing them.

A list of U.S. states and territories declaring emergency declarations and details on licensing waivers.